Quantitative angiogenesis assays: progress and problems

Same author

[Molecular epidemiological characteristics of human coronavirus NL63 in Shanghai City from 2019 to 2024].

Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine]·2025

Same author

Sacituzumab tirumotecan in participants with advanced or metastatic urothelial carcinoma and disease progression after chemotherapy and immune checkpoint inhibitors.

Annals of oncology : official journal of the European Society for Medical Oncology·2025

Same author

[Analysis of discordant results between multiplex fluorescence PCR-capillary electrophoresis for microsatellite instability (MSI) detection and immunohistochemistry (IHC) for mismatch repair (MMR) protein expression in gastrointestinal adenocarcinoma].

Zhonghua zhong liu za zhi [Chinese journal of oncology]·2025

Same author

MFSnet: a multi-scale feature screening network for chicken counting in dense environments.

British poultry science·2025

Same author

Bulumtatug Fuvedotin (BFv, 9MW2821), a next-generation Nectin-4 targeting antibody-drug conjugate, in patients with advanced solid tumors: a first-in-human, open-label, multicenter, phase I/II study.

Annals of oncology : official journal of the European Society for Medical Oncology·2025

Same author

Mitophagy drives maldifferentiation of tissue-resident memory T cells in patients with rheumatoid arthritis.

Scandinavian journal of rheumatology·2024

Same journal

Why high scores do not mean application readiness for health AI.

Nature medicine·2026

Same journal

Polypill for heart failure with reduced ejection fraction: the POLY-HF randomized trial.

Nature medicine·2026

Same journal

Biological aging might help to explain the rising risk of early-onset cancer.

Nature medicine·2026

Same journal

Innate immune responsiveness predicts enhanced cellular immunity and symptomatic disease after controlled human influenza infection.

Nature medicine·2026

Same journal

A meta-analysis of the long-term effects of antihypertensive therapy on the risk of major cardiovascular disease across 51 randomized trials.

Nature medicine·2026

Same journal

Blood-based circular RNAs for early diagnosis of Alzheimer's disease.

Nature medicine·2026

Related Experiment Videos

Quantitative angiogenesis assays: progress and problems

Related Concept Videos

[Molecular epidemiological characteristics of human coronavirus NL63 in Shanghai City from 2019 to 2024].

Sacituzumab tirumotecan in participants with advanced or metastatic urothelial carcinoma and disease progression after chemotherapy and immune checkpoint inhibitors.

[Analysis of discordant results between multiplex fluorescence PCR-capillary electrophoresis for microsatellite instability (MSI) detection and immunohistochemistry (IHC) for mismatch repair (MMR) protein expression in gastrointestinal adenocarcinoma].

MFSnet: a multi-scale feature screening network for chicken counting in dense environments.

Bulumtatug Fuvedotin (BFv, 9MW2821), a next-generation Nectin-4 targeting antibody-drug conjugate, in patients with advanced solid tumors: a first-in-human, open-label, multicenter, phase I/II study.

Mitophagy drives maldifferentiation of tissue-resident memory T cells in patients with rheumatoid arthritis.

Why high scores do not mean application readiness for health AI.

Polypill for heart failure with reduced ejection fraction: the POLY-HF randomized trial.

Biological aging might help to explain the rising risk of early-onset cancer.

Innate immune responsiveness predicts enhanced cellular immunity and symptomatic disease after controlled human influenza infection.

A meta-analysis of the long-term effects of antihypertensive therapy on the risk of major cardiovascular disease across 51 randomized trials.

Blood-based circular RNAs for early diagnosis of Alzheimer's disease.

Related Experiment Videos

Quantitative angiogenesis assays: progress and problems

Related Concept Videos

Related Articles

[Molecular epidemiological characteristics of human coronavirus NL63 in Shanghai City from 2019 to 2024].

Sacituzumab tirumotecan in participants with advanced or metastatic urothelial carcinoma and disease progression after chemotherapy and immune checkpoint inhibitors.

[Analysis of discordant results between multiplex fluorescence PCR-capillary electrophoresis for microsatellite instability (MSI) detection and immunohistochemistry (IHC) for mismatch repair (MMR) protein expression in gastrointestinal adenocarcinoma].

MFSnet: a multi-scale feature screening network for chicken counting in dense environments.

Bulumtatug Fuvedotin (BFv, 9MW2821), a next-generation Nectin-4 targeting antibody-drug conjugate, in patients with advanced solid tumors: a first-in-human, open-label, multicenter, phase I/II study.

Mitophagy drives maldifferentiation of tissue-resident memory T cells in patients with rheumatoid arthritis.

Why high scores do not mean application readiness for health AI.

Polypill for heart failure with reduced ejection fraction: the POLY-HF randomized trial.

Biological aging might help to explain the rising risk of early-onset cancer.

Innate immune responsiveness predicts enhanced cellular immunity and symptomatic disease after controlled human influenza infection.

A meta-analysis of the long-term effects of antihypertensive therapy on the risk of major cardiovascular disease across 51 randomized trials.

Blood-based circular RNAs for early diagnosis of Alzheimer's disease.